Clinical Trial Update: Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating clofarabine, cytarabine, and G-CSF in patients with myelodysplastic syndromes has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)
• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: University of Nebraska | Conditions: Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-04-13